Abstract
Development of a Novel Humanized BCMA-Directed CAR for Multiple Myeloma: Robust Activity and Low Toxicity in Preclinical Studies
Published Version
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have